Zymeworks (ZYME) Interest & Investment Income (2021 - 2026)
Zymeworks recorded quarterly Interest & Investment Income of $2.7 million in Q1 2026, down 8.87% quarter-over-quarter from $3.0 million in Q4 2025, and down 20.82% year-over-year from $3.4 million in Q1 2025.
Zymeworks' Interest & Investment Income history runs 6 years deep, the most recent figure standing at $2.7 million for Q1 2026.
- In Q1 2026, Interest & Investment Income fell 20.82% year-over-year to $2.7 million; the TTM figure through Mar 2026 stood at $12.6 million (down 27.54% YoY), while the FY2025 annual figure was $13.4 million, down 33.03% from the prior year.
- Interest & Investment Income came in at $2.7 million for Q1 2026 at Zymeworks, down from $3.0 million in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $5.9 million in Q1 2024 to a low of $302000.0 in Q1 2022.
- A 5-year average of $3.5 million and a median of $3.5 million in 2025 frame the typical range for Interest & Investment Income.
- Across the five-year window, Interest & Investment Income jumped 1491.06% in 2023 and sank 42.16% in 2025, its largest moves.
- Zymeworks' Interest & Investment Income stood at $1.7 million in 2022, then jumped by 191.34% to $5.0 million in 2023, then slipped by 19.15% to $4.1 million in 2024, then declined by 27.12% to $3.0 million in 2025, then retreated by 8.87% to $2.7 million in 2026.
- According to Business Quant data, Interest & Investment Income over the past three periods registered $2.7 million, $3.0 million, and $3.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 7.90 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 114.80 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 305,000.00 |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 26.60 Mn |
| 10 | Zymeworks | 1.84 Bn | 1.47 Bn | - | 2.71 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.71 Mn |
| Dec 31, 2025 | 2.98 Mn |
| Sep 30, 2025 | 3.53 Mn |
| Jun 30, 2025 | 3.43 Mn |
| Mar 31, 2025 | 3.42 Mn |
| Dec 31, 2024 | 4.08 Mn |
| Sep 30, 2024 | 4.79 Mn |
| Jun 30, 2024 | 5.15 Mn |
| Mar 31, 2024 | 5.92 Mn |
| Dec 31, 2023 | 5.05 Mn |
| Sep 30, 2023 | 5.03 Mn |
| Jun 30, 2023 | 4.83 Mn |
| Mar 31, 2023 | 4.81 Mn |
| Dec 31, 2022 | 1.73 Mn |
| Sep 30, 2022 | 1.13 Mn |
| Jun 30, 2022 | 436,000.00 |
| Mar 31, 2022 | 302,000.00 |
| Dec 31, 2021 | 296,000.00 |
| Sep 30, 2021 | 340,000.00 |